Prelude Therapeutics Incorporated PRLD
As ofNov 20, 2026, 2:13 PM EST
- YTD
- +10.34%
- 1 year
- +100.00%
Held by funds
40 US ETFs and mutual funds hold PRLD · largest positions
- VTI 0.00% of fund $4.63M
- IWM 0.00% of fund $2.50M
- FSSNX 0.01% of fund $1.70M
- VXF 0.00% of fund $1.34M
- IWO 0.01% of fund $928.34K
- VTWO 0.00% of fund $636.82K
- FSMAX 0.00% of fund $536.66K
- IWC 0.02% of fund $297.48K
- MDSKX 0.00% of fund $201.37K
- BUSM 0.19% of fund $200.00K
- FECGX 0.01% of fund $152.71K
- VTWG 0.01% of fund $117.25K
- DFMC 0.00% of fund $75.71K
- VBINX 0.00% of fund $73.08K
- VITPX 0.00% of fund $71.51K
- DFAS 0.00% of fund $68.64K
- OMFS 0.03% of fund $66.16K
- SMMD 0.00% of fund $55.46K
- IWMW* MX 0.00% of fund $30.36K
- BSMAX 0.00% of fund $28.82K
Ownership
- Institutions 85.0%
- Insiders 9.36%
- Public and other holders 5.66%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 30.14% | 16,589,442 | 20.57M | Sep 29, 2024 |
| Baker Bros. Advisors, LP | 18.40% | 10,123,824 | 12.55M | Sep 29, 2024 |
| Deerfield Management Company, L.P. (Series C) | 6.84% | 3,766,120 | 4.67M | Sep 29, 2024 |
| Boxer Capital, LLC | 3.10% | 1,708,187 | 2.12M | Sep 29, 2024 |
| Price (T.Rowe) Associates Inc | 1.99% | 1,097,599 | 1.36M | Sep 29, 2024 |
| Blackrock Inc. | 1.92% | 1,058,316 | 1.31M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Price (T.Rowe) Health Sciences Fund | 1.47% | 809,844 | 1.00M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 1.31% | 720,427 | 893.33K | Sep 29, 2024 |
| iShares Russell 2000 ETF | 0.65% | 358,702 | 444.79K | Oct 30, 2024 |
| MFS New Discovery Fund | 0.60% | 327,699 | 406.35K | Aug 30, 2024 |
| Vanguard Extended Market Index Fund | 0.38% | 207,507 | 257.31K | Sep 29, 2024 |
| Price (T.Rowe) Small-Cap Value Fund | 0.32% | 178,089 | 220.83K | Sep 29, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs PRLD, and what each was last paid
Krishna Vaddi, Founder, Chief Executive Officer & DirectorAverage age 57
| Name | Title | Pay | Age |
|---|---|---|---|
| Krishna Vaddi | Founder, Chief Executive Officer & Director | $935K | 60 |
| Bryant David Lim | Chief Financial Officer, Chief Legal Officer & Corporate Secretary | $681K | 55 |
| Peggy A. Scherle | Chief Scientific Officer | $674K | 64 |
| Andrew Combs | Executive Vice President & Chief Chemistry Officer | $562K | 59 |
| Madhu Pudipeddi | Senior Vice President of Technical Operations | — | — |
| Wan-Jen Hong | Senior Vice President of Clinical Development | — | 47 |
| Naveen Babbar | Senior Vice President of Translation Medicine | — | — |
| Robert A. Doody Jr. | Senior Vice President of Investor Relations | — | — |
| Aimee Crombie | Senior Vice President and Head of Strategic Planning & Operations | — | — |
| Michele Porreca | Chief People Officer | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BONITA DAVID P. M.D. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | May 21, 2023 | 0 |
| CHARDONNET LAURENT | Chief Financial Officer | Purchase | May 22, 2023 | 42,165 |
| HUANG JANE | President | Conversion of Exercise of derivative security | Oct 3, 2024 | 63,341 |
| LIM BRYANT DAVID | Chief Financial Officer | Purchase | Dec 18, 2024 | 27,400 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | May 21, 2023 | 0 |
| VADDI KRISHNA | Chief Executive Officer | Purchase | Dec 18, 2024 | 0 |
